
Clotsafe 75mg Tablet
Marketer
MSN Laboratories
Salt Composition
Clopidogrel (75mg)
Overview Clotsafe 75mg Tablet
CardioGuard 75mg tablets are an antithrombotic agent, reducing the risk of dangerous blood clot formation within blood vessels. This minimizes the likelihood of heart attack or stroke. Widely prescribed for cardiovascular protection, CardioGuard 75mg is indicated for individuals at elevated risk of heart disease. This includes those with peripheral arterial disease (reduced blood flow due to narrowed arteries), recent myocardial infarction or cerebrovascular accident, cardiac arrhythmias, and post-specific cardiac procedures like stent placement. It's also employed adjunctively with other medications to manage myocardial infarction and certain types of angina pectoris. This medication can be taken with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as discontinuation increases the risk of cardiovascular events. The most frequent adverse effect is bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be prolonged. While typically mild and self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in individuals with active internal bleeding, such as gastric ulcers or intracranial hemorrhage. Prior to commencement, inform your physician of any bleeding disorders, recent significant trauma, or upcoming surgery. Temporary cessation may be necessary before scheduled surgical or dental interventions.
Uses of Clotsafe 75mg Tablet
Avert cardiac arrest and cerebrovascular accident.
Major Benefits of Clotsafe 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 75mg Clotsafe tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended.
Common Side effects of Clotsafe 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Clotsafe 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clotsafe 75mg Tablets can be consumed with or without food; however, consistent timing is recommended.
How Clotsafe 75mg Tablet works:
ThromboGuard 75mg tablets inhibit platelet aggregation, a key process in blood clot formation. This antiplatelet agent reduces the risk of cardiovascular events such as stroke and myocardial infarction by preventing clot development.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Clotsafe 75mg tablets with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Clotsafe 75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Clotsafe 75mg tablets while breastfeeding is likely safe. Preliminary human studies indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Clotsafe 75mg Tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment can safely use Clotsafe 75mg tablets without requiring any modification to the prescribed dosage.
LiverSAFE IF PRESCRIBED
Clotsafe 75mg tablets can be administered to patients with hepatic impairment without requiring a modification to the prescribed dosage.
What if you forget to take Clotsafe 75mg Tablet :
Should you forget to take your Clotsafe 75mg Tablet, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Clotsafe 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alkyl esters |
| Developing Habits | No. |
| Type of Treatment | KINSHIP |
| Behavior Class | ADP receptor antagonists (P2Y12 inhibitors) |
